Transfection of L929 cells with complement subcomponent C1q B-chain antisense cDNA inhibits tumor necrosis

Related Experiment Videos

H Jiang1, C A Stewart, S Y Tan

  • 1Oklahoma Medical Research Foundation, Oklahoma City 73104-5046, USA.

Cellular Immunology
|February 1, 1996
PubMed

Insights

Complement C1q protein is essential for tumor necrosis factor-alpha (TNF-α) to bind L929 cells, mediating cell death and nitric oxide (NO) production. Inhibiting C1q synthesis blocks these TNF-α effects.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Tumor necrosis factor-alpha (TNF-α) is a key cytokine in inflammation and immunity.
  • The role of complement subcomponent C1q in TNF-α signaling is not fully understood.

Purpose of the Study:

  • To investigate the role of C1q in TNF-α-mediated cytotoxicity and nitric oxide (NO) generation in L929 cells.

Main Methods:

  • L929 cells were transfected with C1q B-chain antisense plasmid.
  • TNF-α binding, cytotoxicity, and NO generation were assessed.
  • Effects of soluble C1q were evaluated.

Main Results:

  • C1q B-chain antisense transfection reduced TNF-α binding and cytotoxicity.
  • Nitric oxide generation was inhibited by C1q B-chain antisense transfection.
  • Soluble C1q restored TNF-α binding and cytotoxic response.

Conclusions:

  • Endogenously synthesized C1q is required for TNF-α binding to L929 cells.
  • C1q is a prerequisite for TNF-α-mediated cytotoxicity and NO generation.

Related Concept Videos